Encompass Health Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.6% | +18.8% | -9.0% | +23.2% | +4.1% | +3.5% | -6.4% | +0.2% | +27.8% | -9.5% | -9.7% | – | |
| – | +4.2% | +0.3% | +3.7% | +7.5% | -0.5% | +1.5% | +0.9% | +3.1% | +16.5% | -9.1% | +3.6% | – | |
| – | -2.2% | -30.6% | +46.2% | -5.1% | -3.1% | -24.0% | +50.5% | +0.0% | +28.7% | -37.5% | +120.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -149.1% | – | – | – | -91.4% | -367.9% | – | – | +672.2% | -343.2% | – | – | |
| – | +51.7% | -37.4% | +12.6% | -6.0% | +34.7% | -17.9% | -3.8% | +19.2% | +22.6% | -29.2% | +35.7% | – | |
| – | -50.7% | -42.8% | +28.9% | +12.5% | +26.1% | -22.2% | +4.4% | +21.7% | +18.0% | -36.8% | +57.0% | – | |
| – | -0.7% | +6.7% | -6.3% | +0.7% | +13.3% | +5.9% | -5.0% | -0.6% | +11.8% | +6.8% | -6.9% | – | |
| – | -75.0% | +12,000.0% | +38.8% | -59.5% | +10.3% | +328.0% | -23.1% | +0.8% | +206.8% | -6.3% | +3.6% | – | |
| – | – | – | – | – | -38.2% | -77.1% | +11.5% | +28.3% | – | +114.8% | -38.6% | – | |
| – | -33.9% | +35.6% | +9.3% | +38.8% | +68.6% | -13.6% | -30.8% | +25.5% | -12.4% | +3.3% | -25.0% | – | |
| – | – | – | -86.3% | +78.7% | -551.2% | – | – | -399.3% | – | +557.6% | -149.4% | – | |
| – | -131.5% | – | -39.1% | +98.8% | -33.4% | +56.7% | -9.7% | -26.1% | +39.4% | +29.1% | -58.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.